POST-VACCINATION IMMUNITY TO MEASLES IN CHILDREN WHO HAVE HAD COVID

Authors

  • Kenjayeva Dilorom Toshtemirovn Termez branch of Tashkent medical academy

Abstract

Patients with juvenile idiopathic arthritis (JIA) may have low protective levels of antibodies to vaccine antigens due to the immunologic features of the disease, disrupted vaccination schedules, and use of immunosuppressive medications.

The purpose of the study was to study the state of post-vaccination immunity and determine the factors associated with the preservation of the protective level of antibodies in patients with JIA.

References

Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007; 369(9563):767–778. doi: 10.1016/S0140-6736(07)60363-8.

Cassidy JT, Petty RE. Textbook of pediatric rheumatology. Elsevier Saunders; 2005. 792 р.

Beukelman T, Xie F, Chen L, et al; SABER Collaboration. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthrit Rheum. 2012;64(8):2773–2780. doi: 10.1002/art.34458.

Downloads

Published

2024-01-30

How to Cite

POST-VACCINATION IMMUNITY TO MEASLES IN CHILDREN WHO HAVE HAD COVID. (2024). INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION, 1(1), 259-260. https://universalconference.us/universalconference/index.php/icmse/article/view/350